Yahoo! Finance Search - Finance Home - Yahoo! - Help

Tuesday, October 21 2014 8:25pm ET - U.S. Markets Closed.
Industry Center - Biotechnology
Industry Center > Biotechnology > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Biotechnology News
Latest News
Tuesday, Oct 21, 2014
·Biogen Leads 5 Top Biotech Stocks As Earnings Loom
at Investor's Business Daily, Inc. - 29 minutes ago
·Third Point urges Amgen to consider breakup
AP - 49 minutes ago
·Celgene Rises 8% In Two Days On Crohn's Disease Drug Data
Investor's Business Daily, Inc. - 1 hour, 38 minutes ago
·Ebola vaccine could be ready in 3 months: CEO
at CNBC - 1 hour, 40 minutes ago
·Final Glance: Biotechnology companies
AP - 2 hours, 23 minutes ago
·[$$] FDA Panel Recommends Expanded Approval of CF Drug
at The Wall Street Journal Online - 2 hours, 31 minutes ago
·FDA panel votes to expand use of Vertex cystic fibrosis drug
Reuters - 2 hours, 43 minutes ago
·NewLink-Roche Ink Deal for Oncology Candidate Development - Tue 5:05 pm ET
·Gilead Sciences to Release Third Quarter 2014 Financial Results on Tuesday, October 28, 2014
Business Wire - Tue 5:00 pm ET
·Pacific Biosciences to Incur Narrower-than-Expected Q3 Loss - Tue 4:50 pm ET
·FDA Advisory Committee Recommends Approval of KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation
Business Wire - Tue 4:47 pm ET
·[video] How to Land $400 Million in Funding
at MarketWatch - Tue 4:46 pm ET
·Will BioMarin (BMRN) Disappoint This Earnings Season? - Tue 4:30 pm ET
·Cellular Dynamics to Present at the 2014 Medical Innovation Summit
GlobeNewswire - Tue 4:30 pm ET
·Cubist beats Street 3Q forecasts
AP - Tue 4:29 pm ET
·The Plan to Drive Amgen Shares Up Over 70%
- Tue 4:22 pm ET
·Third Point's Loeb urges breakup of biotech company Amgen
Reuters - Tue 4:22 pm ET
·Will Alexion (ALXN) Earnings Suffer Due to Higher Costs? - Tue 4:05 pm ET
·Esperion Therapeutics Announces Closing of Follow-On Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock
Business Wire - Tue 4:05 pm ET
·Synageva BioPharma Starts Rolling Submission Of A Biologics License Application To The FDA For Sebelipase Alfa
PR Newswire - Tue 4:05 pm ET
More Latest News...
Sponsor Results
Shimadzu Life Science
Develop, Accelerate, Integrate with All Your Life Science Needs
Fix .BIZ
Download to fix Windows Fix File Associations errors! (Recommended)
Biotechnology News
Manage Cloud Resources from the Data Center. Expert Tips.
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Biotechnology Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?